For nearly two decades, the attorneys and staff at Douglas & London have had the privilege of representing those injured by the negligent or fraudulent actions of others.
Unmatched Results
Whether our clients were injured by a single event, such as a car accident, or are one of many injured by a harmful pharmaceutical or vaccine, defective medical device, or through environmental exposure, Douglas & London vigorously fights for every client to achieve the best result possible.
No Fee Unless
We Win
Book a Free Consultation
"*" indicates required fields
No Fee Unless
We Win
Firm Partner Stephanie O’Connor served on the trial team that secured a $140 million verdict against AbbVie, Inc. on behalf of a man who was injured as a result of his use...
Read MoreFirm partner Gary J. Douglas served as lead trial counsel and secured a $27.8 million verdict in the first and only plaintiff’s victory against Bayer and Janssen Pharmaceuticals on behalf of a...
Read MoreFirm founders Gary J. Douglas and Michael A. London secured the first verdict in the history of the State of New York against the tobacco industry for the death of a 58-year-old...
Read MoreFirm partner Gary J. Douglas won a trial on behalf of a 16 year old whose skull was fractured when he was struck by a New York City subway.
Firm partner Gary J. Douglas obtained a jury verdict against Johnson & Johnson subsidiary, Ethicon Endosurgery, on behalf of the family of a 45-year-old man who died after a staple gun misfired...
Read MoreJury verdict against Merck & Co. on behalf of a 72-year-old Florida woman who suffered a disabling and disfiguring jaw disease as result of taking the osteoporosis drug Fosamax. Of note, Gary...
Read MoreFirm partner Gary J. Douglas secured this monumental verdict for a construction worker who lost his vision in one eye when a caustic substance splashed his face.
For construction worker whose leg was fractured after he fell four stories in a scaffold collapse.
Our firm’s involvement and participation in the Yaz®/Yasmin® product liability litigation resulted in Bayer paying over $2 billion to the approximately 20,000 injured claimants. Firm partner Michael A. London played a pivotal...
Read MoreOur firm’s involvement and participation in the Zyprexa® product liability litigation yielded a $690 million settlement on behalf of approximately 8,000 injured plaintiffs. Michael A. London played a pivotal role, holding the...
Read MoreOur firm’s involvement and participation in the C8 litigation against DuPont resulted in a $670.6 million settlement on behalf of approximately 3,550 plaintiffs. Firm partner Gary J. Douglas tried three cases to...
Read MoreSettlement on behalf of approximately 4,400 claimants injured by use of the drug Pradaxa. Firm Partner Michael A. London served as co-lead counsel to oversee the entire litigation and was one of...
Read MoreSettlements for 933 clients of our firms clients who were injured as a result of using a prescription medication manufactured by a Fortune 50 pharmaceutical company.
Confidential settlement where our firm represented 152 clients who were injured as a result of using a prescription drug manufactured by a Fortune 50 pharmaceutical company.
Confidential settlements with multiple manufacturers of women’s health-related medical devices on behalf of 1,015 women.
Confidential settlement on behalf of 160 clients for a prescription medication manufactured by a Fortune 500 company.
Unmatched Court-Appointed Leadership and Peer Respect
In prosecuting these cases, firm co-founding partners, Gary J. Douglas and Michael A. London, have served in leadership roles as well as trial counsel in some of the largest national multidistrict litigations in recent years.
By way of example, firm partner Michael London has been appointed to, and served, as lead or liaison counsel on numerous Plaintiffs’ Steering Committees in these national mass tort and complex litigations.
Formal lead and liaison counsel roles and results
- Vice-Chair of Plaintiffs’ Steering Committee – In re: Zyprexa Products Liability Litigation, MDL-1596, before the Honorable Jack B. Weinstein in the United States District Court for the Eastern District of New York (status: resolved, $700 million settlement of approximately 8,000 claims);
- Co-Lead Counsel of Plaintiffs’ Steering Committee – In re: Yasmin and Yaz (Drospirenone) Marketing Sales Practices and Products Liability Litigation, MDL-2100, before the Honorable David R. Herndon in the United States District Court for the Southern District of Illinois (status: over 99.9% of the over 17,000 claims resolved through individual and mass semi-confidential settlements of claims in federal and state courts with the defendants paying over $2 billion);
- Co-Lead Counsel and Liaison Counsel for Plaintiffs’ Steering Committee – In re: Bayer Corp. Combination Aspirin Products Marketing and Sales Practice Litigation, MDL-2023, before the Honorable Brian M. Cogan in the United States District Court for the Eastern District of New York (status: resolved, $15 million class settlement);
- Co-Lead Counsel of Plaintiffs’ Steering Committee – In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation, MDL-2385, before the Honorable David R. Herndon in the United States District Court for the Southern District of Illinois (status: resolved, $650 million settlement of approximately 4,000 claims);
- Liaison Counsel and Plaintiffs’ Executive Committee Member – In re: Ortho Evra Products Liability Litigation, MDL-1742, before the late Honorable David S. Katz in the United States District Court for the Northern District of Ohio (status: resolved, individual confidential settlements of approximately 3,000 claims in federal and state courts);
- Co-Liaison Counsel for all Plaintiffs – In re: Levaquin Litigation, centralized and consolidated litigation before the late Honorable Carol E. Higbee in the Superior Court of New Jersey, Atlantic County (status: resolved, individual confidential settlements of hundreds of claims in federal and state courts); and
- Co-Lead Counsel of Plaintiffs’ Steering Committee – In re: E.I. du Pont de Nemours and Company C-8 Personal Injury Litigation, MDL-2433, before the Honorable Edmund A. Sargus, Jr., pending in the United States District Court for the Southern District of Ohio (status: resolved, $671 million settlement of approximately 3600 claims).
- Co-Lead Counsel of Plaintiffs’ Steering Committee – In re: Invokana (Canagliflozin) Products Liability Litigation, MDL-2750, before the Honorable Brian Martinotti in the United States District Court for the District of New Jersey, (status: resolutions spending via individual confidential settlements of approximately 2000 claims).
Notably, in the eight national mass tort litigations for which Mr. London served as co-lead counsel or as liaison counsel, settlements were accomplished in the span of, a highly efficient, 18 to 37 months from when MDL centralization occurred until announcement of settlement parameters, and as noted, this range includes trials being conducted and settlements days before trial.
Mr. London has also represented hundreds of women exposed, in utero, to the drug Diethylstilbestrol (“DES”). He and the firm also have represented and continues to represent children and families who were victims of the medical device/procedure Chorionic Villi Sampling, as well as other toxic and mass torts for which formal Plaintiffs’ Steering Committees were not established.
Nationally Acclaimed Trial Success Record
Moreover, Mr. Douglas and the firm have been asked to serve as lead trial counsel in other significant mass tort cases that settled before trial. Mr. Douglas and the firm were co-lead trial counsel in one of the first Ortho Evra birth control cases set for trial; Mr. Douglas and the firm being co-lead trial counsel in the first Yaz/Yasmin case set for trial in January 2012 as part of MDL-2100, which was stayed for global settlement discussions 11 days before trial and; Mr. Douglas and the firm designated as lead trial counsel in the first Pradaxa case in MDL-2385, which was stayed due to a global settlement.
Mr. Douglas’s impressive record of trial success has earned him national acclaim and recognition. Mr. Douglas is a past recipient of the Clarence Darrow Award, an honor bestowed upon those lawyers who best embody the attributes and skills of the legendary trial attorney and champion of the underdog, Clarence Darrow. Most recently, in April 2018, Mr. Douglas became one of the youngest lawyers ever inducted in the Trial Lawyer Hall of Fame in Philadelphia, Pennsylvania, an organization that recognizes only those trial lawyers who have established themselves as true champions and crusaders for American justice.
At the Forefront of Complex Nationwide Litigation
In addition to the firm’s founding partners, Douglas & London partner Stephanie O’Connor likewise has served and currently serves both as a member of several trial teams and/or in leadership positions in multiple complex nationwide litigations. Ms. O’Connor’s appointments include Co-Lead Counsel of Plaintiffs’ Steering Committee, before the Honorable Claire Cecchi in the United States District Court for the District of New Jersey, (status: litigation is approximately one year into its MDL); Plaintiffs’ Executive Committee, and Science Chairperson – In re: Actos (Pioglitazone) Products Liability Litigation, MDL-2299, before the Honorable Rebecca F. Doherty in the United States District Court for the Western District of Louisiana (status: resolved, $9 billion verdict against the defendants and a $2.4 billion settlement on behalf of over 9,000 plaintiffs.); Plaintiffs’ Steering Committee – In re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation, MDL-2342, before the Honorable Cynthia M. Rufe in the United States District Court for the Eastern District of Pennsylvania (status: pending); Plaintiffs’ Steering Committee – In re: Power Morcellator Products Liability Litigation, MDL-2652, before the Honorable Kathryn H. Vratil in the United States District Court of Kansas (status: resolved, confidential settlements); Plaintiffs’ Steering Committee – In re: Silicone Gel Breast Implant Prods. Liab. Litig, NY State Consolidated Action with concomitant routine appearances in MDL-926 (status: resolved).
On the trial side, in 2017, Ms. O’Connor served on the trial team that secured a $140 million verdict against AbbVie, Inc., in the Testosterone Replacement Therapy litigation case (Konrad v. AbbVie, Inc.). Ms. O’Connor and the entire trial team were nominated as one of eight trial teams of the year by the National Trial Lawyers Association. This followed Ms. O’Connor’s incredible contribution to the first bellwether trial in the Actos litigation that resulted in a $9 billion verdict against Takeda in 2014 (Allen v. Takeda Pharmaceuticals, Inc.).
In the environmental context, in particular, as noted above, Gary Douglas successfully represented plaintiffs at trials against chemical giant DuPont involving water contamination by the toxic chemical C-8, resulting in verdicts of $1.6 million, $5.6 million and $12.5 million. Mr. London, who, as noted above, was also court appointed co-lead counsel in the C-8 cases, served as the primary negotiator in achieving a global $671 million settlement for all of those cases. All three were nominated as a trial team of the year in 2017, along with Ms. O’Connor’s work. This marks the first time that one law firm had multiple nominations for different members on different trials in the same year.
Douglas & London is a National Firm
Although the law firm of Douglas & London is headquartered in New York, we represent clients from all 50 states, plus Washington, D.C. and Puerto Rico.
Not only does Douglas & London have clients from all across the country but receive referrals from law firms from the states listed below.
Douglas & London is also proud of our standing in the legal community. We work closely with law firms across the country including firms based in Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Washington, West Virginia, Wisconsin, Wyoming and Washington DC.
Landmark Verdicts & Settlements
Xarelto | $28mm
$28 million verdict against Janssen and Bayer on behalf of client who was injured by Xarelto. Gary Douglas served as lead counsel.
C8 | $670.7 mm
Douglas & London won a series of record-shattering settlements in the multi-district litigation, earning more than $700 million in punitive damages after juries agreed DuPont had acted with an“‘conscious disregard”‘ for the health and well-being of the families living along the river in Ohio and West Virginia
Confidential | $48mm
Confidential settlement for 1,215 Douglas & London clients who were injured following the implementation of a defective women’s healthcare product.
Pradaxa | $650mm
$650 million settlement on behalf of approximately 3,900 claimants who were injured by the drug Pradaxa. Firm Partner Michael London was appointed as one of the five co-lead plaintiffs’ counsel to oversee the entire litigation by Judge David R. Herndon of the U.S. District Court for the Southern District of Illinois.
Takeda Pharmaceuticals | $9bb
Verdict for diabetes drug manufactured by a top-20 pharmaceutical company which caused bladder cancer.
Confidential | $150mm
Verdict of Testosterone Replacement (Low-T) drug which was linked to abuse and “off-label” use due to aggressive and misleading marketing. Life-threatening side-effects included strokes, heart attacks, high blood pressure, blood clots, and death.
Confidential | $2.1bb
Birth control pill which was recalled by the FDA to alter its advertising campaign and packaging to elevate the dangers and to stop marketing their products for purposes not approved by the FDA. Michael London served as co-lead counsel and helped recovered over $2 billion for all clients involved, including over $123 million on behalf of Douglas & London clients.
Bayer Combo Aspirin | $15mm
Class action lawsuit against Bayer which alleged that Bayer falsely represented to consumers that its over-the-counter combination aspirin drugs, Bayer Women’s Low Dose Aspirin + Calcium and Bayer with Heart Advantage delivered certain health benefits, which they, in fact, did not. Michael A. London was co-lead counsel in this case.
Confidential | $10mm
Defective medical product which was causing internal pain and injuries. The attorneys at Douglas & London recovered $10 million on behalf of clients and continue to fight against manufacturers who have created other defective hernia mesh products.
Confidential | $14mm
Confidential settlement against multiple manufacturers whose defective products caused copper depletions which resulted in copper-deficiency induced myelopathy, which caused paralysis in extreme cases.
Fosamax | $8mm
Jury verdict against Merck & Co on behalf of a 72-year-old Florida woman who suffered a disabling and disfiguring jaw disease as a result of taking the osteoporosis drug Fosamax. Of note, this was the first win for any plaintiff against Merck & Co in the country relating to Fosamax.
Ethicon Staple Gun | $8mm
Jury verdict against Johnson & Johnson subsidiary, Ethicon Endosurgery, on behalf of the family of a 45-year-old man who died after a staple gun misfired during a weight-loss surgery.
Confidential | $3.1mm
Confidential settlement against Fortune 500 Company for marketing anti-psychotic drug for “off-market” purposes.
Confidential | $14mm
Confidential settlements against 6 manufacturers whose defective devices caused a serious side effect which required life-long treatments to minimize their symptoms.
Confidential | $11.3mm
Confidential settlement where our firm represented 109 clients who were injured as a result of using a prescription drug manufactured by a Fortune 50 pharmaceutical company.
Confidential | $40mm
Confidential settlement on behalf of 160 clients for a prescription medication manufactured by a Fortune 500 company.
Polio Vaccine Case | $4mm
Settlement for the family of a 2½-year-old boy who was given the wrong polio vaccine which caused him to develop polio and quadriplegia, all of which ultimately led to his premature death before he even reached the age of 3.
Confidential | $15mm
Settlement where our firm represented those who were injured as a result of the manufacturer falsely promoting its drug’s safety and failing to disclose the full range of side effects.
Zyprexa | $690 mm
Our firm’s involvement and participation in the Zyprexa® product liability litigation yielded a $690 million settlement on behalf of approximately 8,000 injured plaintiffs, where law firm partner, Michael A. London played a pivotal role, holding the position of Vice-Chair of the Plaintiffs’ Steering Committee responsible for the groundbreaking settlement.
Tobacco | $20m
The first verdict in the history of the State of New York against the tobacco industry for the death of a 58-year-old former smoker of Lucky Strike cigarettes.
Featured News
How To Poison A Planet Premieres Internationally
Douglas & London was proud to sponsor the international premiere of the award-winning documentary, How To Poison A Planet. Featuring actor and activist Mark Ruffalo and the Douglas & London...
Learn MoreChoose a Top Personal Injury Lawyer with Tenacity and a Winning Track Record
At Douglas & London, we can provide you with the legal representation you need to hold the responsible parties accountable and secure the verdict or settlement you deserve. If you or a loved one has been injured, contact Douglas & London at 646-594-1112 or Email to schedule your free case review.
